Michigan Cancer Research Consortium

Recent papers from Michigan Cancer Research Consortium

1. The cervical microbiome in hispanic populations in Texas and Puerto Rico with and without cervical dysplasiaScientific Reports · 2026
2. Restoration of PP2A AαB56αC trimer formation by RPT04402 molecular glue in high-grade uterine cancerScience Translational Medicine · 2026
3. Context-dependent regulation of cytotoxic T lymphocytes by nuclear receptorsThe Journal of Immunology · 2026
4. Sunitinib in Patients With Various Solid Tumors With FGFR1 / 2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyJCO Precision Oncology · 2026
5. Sarcopenia Is Associated With Severe Treatment Toxicity and Mortality in Older Adults With Advanced Cancer: A Secondary AnalysisJournal of Cachexia Sarcopenia and Muscle · 2026
6. Targeting bromodomain and extra-terminal proteins reprograms macrophages and inhibits breast cancer progressionFrontiers in Immunology · 2026
7. Prospective Evaluation of Circulating Tumor DNA in Metastatic Hormone-Sensitive Prostate CancerJCO Precision Oncology · 2026
8. Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 studyFuture Oncology · 2026
9. The National Archive of Computerized Data on Aging (NACDA) Portal: Variable-level discovery and custom metadata and data extraction for aging researchInnovation in Aging · 2026
10. Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancerJCI Insight · 2026
11. Lysosomal metabolism in pancreatic cancer and its crosstalk with host physiologyGenes & Development · 2026
12. Lasting Financial and Professional Impacts Among Survivors of Early-Onset Colorectal CancerDiseases of the Colon & Rectum · 2026
13. Lanreotide for the prevention of postoperative pancreatic fistula (S2408): study protocol for a multicenter randomized controlled trialTrials · 2026
14. A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02Clinical Cancer Research · 2026
15. Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cellsMolecular Therapy Advances · 2026
16. A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight managementObesity Pillars · 2026
17. Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokersArchives of Toxicology · 2026
18. Abstract P48: MULTIMODAL DATA INTEGRATION FOR A PAN-CANCER ASIAN COHORT OF EXCEPTIONAL RESPONDERS AND HYPER-PROGRESSORS TO IMMUNOTHERAPY HIGHLIGHTS UTILITY OF BIOMARKERSCancer Research · 2026
19. Abstract LT01: Spatial Phenotypes Ascribed to Cancers with Extreme Resistance (SPACER) in HR+ HER2- Metastatic Breast Cancer – a Multi-Institutional Use-Case Study of the Translational Research Integration and Support Platform by the Singapore Translational Cancer Consortium (STCC)Cancer Research · 2026
20. Lumpectomy Margins and Local Recurrence in DCISJAMA Surgery · 2026